Director/PDMR Shareholding

Eco Animal Health Group PLC

01 December 2023

 

ECO Animal Health Group plc

(''ECO", the "Company" or the "ECO Group") (AIM: EAH)

Director/PDMR Dealings

ECO Animal Health Group plc, a leader in the development, registration and marketing of pharmaceutical products for global animal health markets, has been notified that on 30 November 2023, David Hallas, Chief Executive Officer, purchased 37,759 ordinary shares of 5 pence each ("Ordinary Shares") at a price of 105.9 pence per share.

Following this transaction, David Hallas' total interest in the Company is 91,153 Ordinary Shares, representing approximately 0.14 per cent. of the Company's issued share capital.

Details of the transactions can be found in the Notification of Dealing Form below.

For further information please contact:

ECO Animal Health Group plc David Hallas (CEO) Christopher Wilks (CFO)	020 8447 8899
IFC Advisory Graham Herring Zach Cohen	020 3934 6630
Singer Capital Markets (Nominated Adviser & Joint Broker) Phil Davies Sam Butcher	020 7496 3000
Investec (Joint Broker) Gary Clarence Lydia Zychowska Carlo Spingardi	020 7597 5970
Equity Development Hannah Crowe Matt Evans	020 7065 2692

About ECO Animal Health

ECO Animal Health Group plc researches, develops and commercialises products for livestock. Our business strategy is to generate shareholder value by achieving the maximum sales potential from the existing product portfolio whilst investing in Research and Development ("R&D") for new products, particularly vaccines, and seeking to in-license new products.

1	Details of the person discharging managerial responsibilities / person closely associated
a)	Name	David Hallas
2	Reason for the notification
a)	Position/status	Chief Executive Officer
b)	Initial notification /Amendment	Initial notification
3	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	ECO Animal Health Group plc
b)	LEI	2138009XN9DJ3YP70B55
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument	Ordinary shares of 5 pence each
	Identification code	GB0032036807
b)	Nature of the transaction	Purchase of Ordinary Shares
c)	Price(s) and volume(s)
			Price(s)	Volume(s)
			105.9 pence	37,759
d)	Aggregated information	N/A - Single transaction
	- Aggregated volume
	- Price
e)	Date of the transaction	30 November 2023
f)	Place of the transaction	London Stock Exchange, AIM

 

END